JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus

TL;DR

**JPMorgan Chase Financial Co. LLC is issuing new securities, watch for impact on JPM's capital structure.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026. This filing is related to a previous registration statement (File No. 333-270004-01) and indicates the offering of securities. For investors, this means JPMorgan Chase Financial Co. LLC is likely raising capital, which could impact the company's financial structure and future growth prospects, potentially affecting the value of JPMorgan Chase & Co. stock.

Why It Matters

This filing signals that JPMorgan Chase Financial Co. LLC is offering new securities, which could dilute existing shares or provide capital for strategic initiatives, directly influencing the parent company's financial health.

Risk Assessment

Risk Level: medium — The filing itself is administrative, but the underlying offering of securities carries inherent market and financial risks for investors.

Analyst Insight

Investors should monitor subsequent filings or news from JPMorgan Chase & Co. (JPM) for details on the terms of the securities offering, including the amount, type, and use of proceeds, to assess potential impacts on JPM's stock.

Key Numbers

• 333-270004-01 — File No. for JPMorgan Chase Financial Co. LLC (Identifies the specific registration statement this prospectus supplements.)
• 333-270004 — File No. for JPMORGAN CHASE & CO (Identifies the specific registration statement for the parent company.)
• 2026-03-24 — Filing Date (The date the 424B2 prospectus was filed with the SEC.)
• 571154 — Size of PRICING SUPPLEMENT document (Indicates the length and detail of the primary offering document.)

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMORGAN CHASE & CO (company) — Parent company of the filer
• 0001665650 (person) — CIK of JPMorgan Chase Financial Co. LLC
• 0000019617 (person) — CIK of JPMORGAN CHASE & CO
• 2026-03-24 (dollar_amount) — Filing Date

Forward-Looking Statements

• JPMorgan Chase Financial Co. LLC will successfully raise capital through this offering. (JPMorgan Chase Financial Co. LLC) — medium confidence, target: 2026-06-30

FAQ

Key Financial Figures

• $1,250,000 — Company LLC Structured Investments $1,250,000 Review Notes Linked to the Common Sto
• $1,000 — f the notes. Minimum denominations of $1,000 and integral multiples thereof The no
• $41.25 — roceeds to Issuer Per note $1,000 $41.25 $958.75 Total $1,250,000 $ 51 ,
• $958.75 — o Issuer Per note $1,000 $41.25 $958.75 Total $1,250,000 $ 51 ,562.50 $
• $1,198,437.50 — 5 Total $1,250,000 $ 51 ,562.50 $1,198,437.50 (1) See " Supplemental Use of Proceed
• $901.80 — en the terms of the notes were set, was $901.80 per $1,000 principal amount note. See
• $0.001 — mon stock of Broadcom Inc., par value $0.001 per share (Bloomberg ticker: AVGO). We
• $155.255 — 50 .00% of the Initial Value, which is $155.255 Pricing Date: On or about March 20, 2
• $310.51 — Stock on the Pricing Date, which was $310.51 Final Value: The closing price of one
• $100.00 — ew Date Call Premium Amount First $100.00 Second $125.00 Third $150.00
• $125.00 — ium Amount First $100.00 Second $125.00 Third $150.00 Fourth $175.00
• $150.00 — $100.00 Second $125.00 Third $150.00 Fourth $175.00 Fifth $200.00
• $175.00 — $125.00 Third $150.00 Fourth $175.00 Fifth $200.00 Sixth $225.00 S
• $200.00 — $150.00 Fourth $175.00 Fifth $200.00 Sixth $225.00 Seventh $250.00
• $225.00 — h $175.00 Fifth $200.00 Sixth $225.00 Seventh $250.00 Eighth $275.00

Filing Documents

• ea0283121-01_424b2.htm (424B2) — 558KB
• ea028312101_ex-filingfees.htm (EX-FILING FEES) — 4KB
• bg1.jpg (GRAPHIC) — 208KB
• bg2.jpg (GRAPHIC) — 269KB
• bg3.jpg (GRAPHIC) — 361KB
• bg4.jpg (GRAPHIC) — 348KB
• bg5.jpg (GRAPHIC) — 400KB
• bg6.jpg (GRAPHIC) — 269KB
• bg7.jpg (GRAPHIC) — 35KB
• bg8.jpg (GRAPHIC) — 35KB
• bg9.jpg (GRAPHIC) — 482KB
• bga.jpg (GRAPHIC) — 198KB
• bgb.jpg (GRAPHIC) — 284KB
• bgc.jpg (GRAPHIC) — 35KB
• 0001213900-26-033382.txt ( ) — 2282KB
• ea028312101_ex-filingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT Marc h 20 , 202 6 Registration Statement Nos . 333 - 270004 and 333 - 270004 - 01 ; Rule 424(b)(2) Pricing supplement to product supplement no. 4-I dated April 13, 2023 , the prospectus and prospectus supplement, each dated April 13, 2023 , and the prospectus addendum dated June 3, 2024 JPMorgan Chase Financial Company LLC Structured Investments $1,250,000 Review Notes Linked to the Common Stock of Broadcom Inc. due March 25, 2031 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek early exit prior to maturity at a premium if, on any Review Date, the closing price of one share of the Reference Stock is at or above the Call Value. The earliest date on which an automatic call may be initiated is March 24, 2027. Investors should be willing to forgo interest and dividend payments and be willing to accept the risk of losing a significant portion or all of their principal amount at maturity. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660MQL2 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S -2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement and "Selected Risk Considerations" beginning on page PS -5 of this pricin g supplement. Neither the Securities and Exchange Commission (the " SEC " ) nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $41.25 $958.75 Total $1,250,000 $ 51 ,562.50 $1,198,437.50 (1) See " Supplemental Use of Proceeds " in this pricing supplement for information about the components of the price to public of the notes . (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $41.25 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See " Plan of Distribution (Conflicts of Interest) " in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $901.80 per $1,000 principal amount note. See " The Estimated Value of the Notes " in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. PS-1 | Structured Investments Review Notes Linked to the Common Stock of Broadcom Inc. Key Terms Issuer: JPMorgan Chase Financial Company LLC , a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Reference Stock: The common stock of Broadcom Inc., par value $0.001 per share (Bloomberg ticker: AVGO). We refer to Broadcom Inc. as " Broadcom ." Call Premium Amount: The Call Premium Amount with respect to each Review Date is set forth below: first Review Date: 10.00% $1,000 second Review Date: 12.50% $1,000 third Review Date: 15.00% $1,000 fourth Review Date: 17.50% $1,000 fifth Review Date: 20.00% $1,000 sixth Review Date: 22.50% $1,000 seventh Review Date: 25.00% $1,000 eighth Review Date: 27.50% $1,000 ninth Review Date: 30.00% $1,000 tenth Review Date: 32.50% $1,000 eleventh Review Date: 35.00% $1,000 twelfth Review Date: 37.50% $1,000 thirteenth Review Date: 40.00% $1,000 fourteenth Review Date: 42.50% $1,000 fifteenth Review Date: 45.00% $1,000 sixteenth Review Date: 47.50% $1,000 final Review Date: 50.00% $1,000 Call Value: 82 .00 % of the Initial Value Barrier Amount: 50 .00% of the Initial Value, which is $155.255 Pricing Date: On or about March 20, 2026 Original Issue Date (Settlement Date): On or about March 25, 2026 Review Dates*: March 24, 2027, June 21, 2027, September 20, 2027, December 20, 2027, March 20, 2028, June 20, 2028, September 20, 2028, December 20, 2028, March 20, 2029, June 20, 2029, September 20, 2029, December 20, 2029, March 20, 2030,

View Full Filing

View this 424B2 filing on SEC EDGAR